Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Inhibrx Biosciences Inc. (NASDAQ: INBX) – FDA Inspections
Company
•United States•Public company, NASDAQ: INBX

Inhibrx Biosciences Inc. (NASDAQ: INBX) – FDA Inspections

Inspection records and compliance data for Inhibrx Biosciences Inc.. Access full analysis and detailed observations. Publicly traded as NASDAQ: INBX.

Sign in to open in Dashboard
Company Profile

This profile covers Inhibrx Biosciences Inc..

FDA documents

Form 483s (1)

  • Form 483s · July 2, 2026
People (1)
Samson O. Oluseye
Person
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Ranbaxy Laboratories, Ltd., Paonta Sahib, India
PharmScript LLC
Herbs, Heirlooms and Homebrew
Gold Crown Natural Products
r. melton enterprises llc
Key Compounding Pharmacy
Extreme Advertising
JW Nutritional LLC Dallas
Draegar Medical Systems, Inc.
Vita Pure Inc
Company Information

Name

Inhibrx Biosciences Inc.

Stock ticker

INBX

Exchange

NASDAQ

Share price

$87.75

Market cap

$1.3B

Price as of

November 13, 2026

FEI Number

3044681688

ID: d13e278b-a848-4ac6-bfdc-3bf8c67f52d9

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.